These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 8268394)

  • 1. Interactive multivariate analysis of bisindolylmaleimides as potent protein kinase C antagonists.
    Mager PP
    Drug Des Discov; 1993; 10(3):231-48. PubMed ID: 8268394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isoenzyme specificity of bisindolylmaleimides, selective inhibitors of protein kinase C.
    Wilkinson SE; Parker PJ; Nixon JS
    Biochem J; 1993 Sep; 294 ( Pt 2)(Pt 2):335-7. PubMed ID: 8373348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitors of protein kinase C. 2. Substituted bisindolylmaleimides with improved potency and selectivity.
    Davis PD; Elliott LH; Harris W; Hill CH; Hurst SA; Keech E; Kumar MK; Lawton G; Nixon JS; Wilkinson SE
    J Med Chem; 1992 Mar; 35(6):994-1001. PubMed ID: 1552513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correspondence analysis of protein kinase C (PKC) inhibition by bis-basic substituted benzamides.
    Gilbert J; Cheminant M; Bignon E; Pons M; Ojasoo T; Doré JC
    Drug Des Discov; 1998 Oct; 15(4):253-67. PubMed ID: 10546070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, SAR studies, and pharmacological evaluation of 3-anilino-4-(3-indolyl) maleimides with conformationally restricted structure as orally bioavailable PKCbeta-selective inhibitors.
    Tanaka M; Sagawa S; Hoshi J; Shimoma F; Yasue K; Ubukata M; Ikemoto T; Hase Y; Takahashi M; Sasase T; Ueda N; Matsushita M; Inaba T
    Bioorg Med Chem; 2006 Sep; 14(17):5781-94. PubMed ID: 16762554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitors of protein kinase C. 3. Potent and highly selective bisindolylmaleimides by conformational restriction.
    Bit RA; Davis PD; Elliott LH; Harris W; Hill CH; Keech E; Kumar H; Lawton G; Maw A; Nixon JS
    J Med Chem; 1993 Jan; 36(1):21-9. PubMed ID: 8421286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. (S)-13-[(dimethylamino)methyl]-10,11,14,15-tetrahydro-4,9:16, 21-dimetheno-1H, 13H-dibenzo[e,k]pyrrolo[3,4-h][1,4,13]oxadiazacyclohexadecene-1,3(2H)-d ione (LY333531) and related analogues: isozyme selective inhibitors of protein kinase C beta.
    Jirousek MR; Gillig JR; Gonzalez CM; Heath WF; McDonald JH; Neel DA; Rito CJ; Singh U; Stramm LE; Melikian-Badalian A; Baevsky M; Ballas LM; Hall SE; Winneroski LL; Faul MM
    J Med Chem; 1996 Jul; 39(14):2664-71. PubMed ID: 8709095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and evaluation of novel 7-azaindazolyl-indolyl-maleimide derivatives as antitumor agents and protein kinase C inhibitors.
    Ye Q; Cao J; Zhou X; Lv D; He Q; Yang B; Hu Y
    Bioorg Med Chem; 2009 Jul; 17(13):4763-72. PubMed ID: 19447039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of anilino-monoindolylmaleimides as potent and selective PKCbeta inhibitors.
    Tanaka M; Sagawa S; Hoshi J; Shimoma F; Matsuda I; Sakoda K; Sasase T; Shindo M; Inaba T
    Bioorg Med Chem Lett; 2004 Oct; 14(20):5171-4. PubMed ID: 15380221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, cytotoxicity and protein kinase C inhibition of arylpyrrolylmaleimides.
    Xu GQ; Zhang C; Zhang L; Zhou XL; Yang B; He QJ; Hu YZ
    Arch Pharm (Weinheim); 2008 May; 341(5):273-80. PubMed ID: 18404777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and discovery of macrocyclic polyoxygenated bis-7-azaindolylmaleimides as a novel series of potent and highly selective glycogen synthase kinase-3beta inhibitors.
    Kuo GH; Prouty C; DeAngelis A; Shen L; O'Neill DJ; Shah C; Connolly PJ; Murray WV; Conway BR; Cheung P; Westover L; Xu JZ; Look RA; Demarest KT; Emanuel S; Middleton SA; Jolliffe L; Beavers MP; Chen X
    J Med Chem; 2003 Sep; 46(19):4021-31. PubMed ID: 12954055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3D-QSAR and molecular docking study on bisarylmaleimide series as glycogen synthase kinase 3, cyclin dependent kinase 2 and cyclin dependent kinase 4 inhibitors: an insight into the criteria for selectivity.
    Dessalew N; Bharatam PV
    Eur J Med Chem; 2007 Jul; 42(7):1014-27. PubMed ID: 17335939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the ATP binding sites of protein kinases using conformationally diverse bisindolylmaleimides.
    Bartlett S; Beddard GS; Jackson RM; Kayser V; Kilner C; Leach A; Nelson A; Oledzki PR; Parker P; Reid GD; Warriner SL
    J Am Chem Soc; 2005 Aug; 127(33):11699-708. PubMed ID: 16104747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of 3-(1H-indol-3-yl)-4-[2-(4-methylpiperazin-1-yl)quinazolin-4-yl]pyrrole-2,5-dione (AEB071), a potent and selective inhibitor of protein kinase C isotypes.
    Wagner J; von Matt P; Sedrani R; Albert R; Cooke N; Ehrhardt C; Geiser M; Rummel G; Stark W; Strauss A; Cowan-Jacob SW; Beerli C; Weckbecker G; Evenou JP; Zenke G; Cottens S
    J Med Chem; 2009 Oct; 52(20):6193-6. PubMed ID: 19827831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of bisindolylmaleimides using a palladium catalyzed cross-coupling reaction.
    Neel DA; Jirousek MR; McDonald JH
    Bioorg Med Chem Lett; 1998 Jan; 8(1):47-50. PubMed ID: 9871626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and protein kinase C inhibitory activities of balanol analogs with replacement of the perhydroazepine moiety.
    Lai YS; Mendoza JS; Jagdmann GE; Menaldino DS; Biggers CK; Heerding JM; Wilson JW; Hall SE; Jiang JB; Janzen WP; Ballas LM
    J Med Chem; 1997 Jan; 40(2):226-35. PubMed ID: 9003521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SAR and 3D-QSAR studies on thiadiazolidinone derivatives: exploration of structural requirements for glycogen synthase kinase 3 inhibitors.
    Martinez A; Alonso M; Castro A; Dorronsoro I; Gelpí JL; Luque FJ; Pérez C; Moreno FJ
    J Med Chem; 2005 Nov; 48(23):7103-12. PubMed ID: 16279768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative molecular moment analysis (CoMMA): 3D-QSAR without molecular superposition.
    Silverman BD; Platt DE
    J Med Chem; 1996 May; 39(11):2129-40. PubMed ID: 8667357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of potent and selective PKC-theta inhibitors.
    Cywin CL; Dahmann G; Prokopowicz AS; Young ER; Magolda RL; Cardozo MG; Cogan DA; Disalvo D; Ginn JD; Kashem MA; Wolak JP; Homon CA; Farrell TM; Grbic H; Hu H; Kaplita PV; Liu LH; Spero DM; Jeanfavre DD; O'Shea KM; White DM; Woska JR; Brown ML
    Bioorg Med Chem Lett; 2007 Jan; 17(1):225-30. PubMed ID: 17055721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of bisindolylmaleimides related to GF109203x and their efficient conversion to the bioactive indolocarbazoles.
    Roy S; Eastman A; Gribble GW
    Org Biomol Chem; 2006 Sep; 4(17):3228-34. PubMed ID: 17036110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.